Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 known ✓ | P25103 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5218006 | 0.84 | — | — | |
| Pyridine SCHEMBL4442754 | 0.83 | NPC1 (0.31) | — | |
| SCHEMBL29626404 | 0.76 | — | — | |
| SCHEMBL29626253 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL2961475 | 0.73 | MAPT (0.36) | — | |
| Hydrochloric Acid SCHEMBL1277363 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL547963 | 0.73 | — | — | |
| SCHEMBL4604431 | 0.72 | — | — | |
| Hydrochloric Acid SCHEMBL6100055 | 0.72 | CRHR1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL2148988 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125499-A1 | CATALYST LIQUID AND POLYMERIZABLE COMPOSITION | RIMTEC CORPORATION (JP) | 2026-05-07 | — | — | US | disclosed |
| EP-4606837-A1 | POLYMERIZABLE COMPOSITION AND NORBORNENE RESIN | RIMTEC Corporation (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-4606836-A1 | CATALYST LIQUID AND POLYMERIZABLE COMPOSITION | RIMTEC Corporation (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-4461720-A1 | CYCLOPENTENE RECOVERY METHOD | Zeon Corporation (JP) | 2024-11-13 | — | — | EP | disclosed |
| EP-1655319-B1 | POLYMERIZABLE COMPOSITION AND FORMED BODY THEREOF | ZEON CORP (JP) | 2012-03-28 | — | — | EP | disclosed |
| US-7893145-B2 | Oxygen-absorbing resin composition | KURARAY CO., LTD. (JP) | 2011-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125499-A1 | CATALYST LIQUID AND POLYMERIZABLE COMPOSITION | TCP1, ROS1, PEAK1 | TACR1 2373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.